DrugPatentWatch Database Preview

Sweden Supplementary Protection Certificates

« Back to Dashboard

Supplementary Protection Certificates

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Country	Patent Number	Supplementary Protection Certificate	SPC Country	SPC Description	SPC Expiration
European Patent Office	1307486	1290022-1	Sweden	PRODUCT NAME: PASIREOTID; REG. NO/DATE: EU/1/12/753/001 20120424
European Patent Office	2209800	1490067-4	Sweden	PRODUCT NAME: COMBINATION OF INSULIN DEGLUDEC AND LIRAGLUTIDE; REG. NO/DATE: EU/1/14/974 20140918
European Patent Office	2203462	1490066-6	Sweden	PRODUCT NAME: SOFOSBUVIR; REG. NO/DATE: EU/1/13/894 20140117
European Patent Office	1436271	1490023-7	Sweden	PRODUCT NAME: VORTIOXETINE ELLER ETT FARMACEUTISKT GODTAGBART SYRAADDITIONSSALT DAERAV; REG. NO/DATE: EU/1/13/891 20131218
European Patent Office	2506844	1890025-8	Sweden	PRODUCT NAME: COMBINATION OF A PHARMACEUTICALLY ACCEPTABLE SALT OF UMECLIDINIUM (E.G. UMECLIDINIUM BROMIDE), VILANTEROL OR A PHARMACEUTICALLY ACCEPTABLE SALT THEROF (E.G. VILANTEROL TRIFENATATE) AND FLUTICASONE FUROATE.; REG. NO/DATE: EU/1/17/1236 20171117